Licensed provider care
Online clinical evaluation and ongoing access to a care team when you have treatment questions.
A weekly weight-management injection, if prescribed
Wegovy® pen prescription online for weight loss
Explore Wegovy with insurance or self-pay options through an online clinical evaluation and continuing weight-care support.
- Average weight loss of about 19% in manufacturer trials at the studied high dose
- FDA-approved weekly GLP-1 injection for weight management
- Insurance or self-pay access may be available, if prescribed
The clinical assessment does not guarantee eligibility, treatment, a prescription, coverage, or medication availability.
Weekly GLP-1 injection
semaglutideWegovy® pen
About the medication
What is the Wegovy pen?
Wegovy is an FDA-approved semaglutide injection used with nutrition and activity changes for eligible people with obesity or overweight plus a related condition.
It acts like a natural GLP-1 hormone involved in appetite and blood-sugar regulation. A provider begins at a low dose and may increase it gradually based on response and tolerability.
How it compares
Insurance or direct self-pay access
- 01
The prefilled pen is injected under the skin once each week.
- 02
Insurance coverage may require prior authorization and can vary by plan.
- 03
Self-pay fulfillment may offer a separate price and direct delivery path.
Access and pricing
Know the path before you decide
Your provider first determines whether prescription treatment is appropriate. You can then review the relevant access option before moving forward.
Insurance or self-pay
First month$199
Ongoing range$199–$399/mo
Reference pricing varies by dose, insurance, pharmacy, and available savings. Medication and membership charges are separate.
Start with a clinical assessmentCheck insurance options for weight careImportant safety information
Prescription GLP-1 treatment is not appropriate for everyone
Semaglutide can cause serious side effects and is not appropriate for everyone. Review the official prescribing information with a licensed clinician.
Explore potential results
What could about 19% in one year look like for you?
Adjust the slider to see a simple illustration using the published study average. It is not a prediction or guarantee.
Illustration based on manufacturer research of the studied high dose in adults with obesity, alongside diet and exercise. Results at other doses differ and individual results vary.
Study-average illustration−48 lb
From 252 lb to about 204 lb
Based on a 19% average; individual results vary.The MOVA care journey
From online assessment to ongoing support
One connected process helps you understand each clinical, access, and fulfillment step.
- 01
Tell us about your health
Complete a secure online assessment about your medical history, goals, and previous weight-care experience.
- 02
Get a licensed-provider review
A licensed healthcare provider reviews your information and may ask follow-up questions before discussing treatment.
- 03
Review your options
If treatment is appropriate, review the provider's recommendation, access path, and total costs before deciding.
- 04
Arrange fulfillment
When prescribed, medication may be delivered or sent to a participating pharmacy, depending on the selected access path.
- 05
Keep your care connected
Check in with your care team for dose guidance, progress tracking, side-effect support, and ongoing clinical review.
MOVA Weight Care
Medication is one part of connected care
If treatment is appropriate, membership keeps clinical support, progress review, and access guidance in one online experience.
Begin your assessmentTreatment support
Guidance for using medication as prescribed, managing common side effects, and building sustainable habits.
Progress check-ins
Regular opportunities to share progress so your provider can review how your care plan is working.
Access guidance
Clear information about self-pay and insurance pathways that may apply to an appropriate prescription.
Using this medication
How is the Wegovy pen used?
If prescribed, the prefilled pen is injected under the skin of the abdomen, thigh, or upper arm once each week. Follow your provider's schedule and the official instructions for use.
Never change a dose or medication schedule without instructions from the prescribing healthcare professional.
Common side effects
What you may want to discuss with a provider
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Stomach pain
- Skin sensations
This is not a complete list. Some reactions can be serious; see the important safety information below.
Ready for the next step?
Find out whether online weight care may be right for you
Meet the care team
Expertise behind a more connected care experience
Explore the clinical leadership and public advisor profiles represented in the MOVA experience, and learn how their areas of expertise can inform thoughtful weight-care education.
An online assessment is reviewed by an appropriately licensed provider; it does not guarantee access to a particular clinician or advisor.
Meet the advisors
Frequently asked questions
Questions about Wegovy® pen
How often is the Wegovy pen used?
It is generally injected once weekly. Dose changes and timing must follow the plan provided by the prescribing clinician.
Can insurance cover Wegovy?
Some plans cover Wegovy and may require prior authorization. Coverage, copays, savings, and pharmacy availability vary.
What is the difference between Wegovy and Ozempic?
Both contain semaglutide, but they have different approved uses, doses, and prescribing information. A provider can explain which options may be relevant.
Does starting the assessment guarantee Wegovy?
No. The assessment starts a clinical review and does not guarantee a prescription, insurance coverage, price, or medication availability.
Important safety information
Know the risks before treatment
Semaglutide can cause serious side effects and is not appropriate for everyone. Review the official prescribing information with a licensed clinician.
- Do not use with a personal or family history of medullary thyroid carcinoma or with MEN 2.
- Do not use during pregnancy; tell your provider if you are pregnant or planning pregnancy.
- Do not combine with another semaglutide medicine or another GLP-1 medicine unless specifically directed by a qualified prescriber.
- Seek medical help for severe abdominal pain, serious allergic symptoms, dehydration, or other urgent reactions.
This overview does not replace the complete prescribing information or advice from a licensed healthcare professional. Tell your provider about your health conditions, allergies, and every medicine or supplement you use.